Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02824731Not ApplicableRecruiting

Comparison of Proton and Photon Radiotherapy of Brain Tumors (ProtoChoice-Hirn)

Role: collaborator

NCT02766686Not ApplicableRecruiting

Preference-based Comparative Study on Definitive Radiotherapy of Prostate Cancer With Protons

Role: collaborator

NCT02731001Not ApplicableUnknown

Proton Therapy to Reduce Acute Normal Tissue Toxicity in Locally Advanced Non-small-cell Lung Cancer

Role: collaborator

NCT02189967Not ApplicableCompleted

Postoperative Radiotherapy of Non-small Cell Lung Cancer: Accelerated vs. Conventional Fractionation

Role: collaborator

All 4 trials loaded